Osemitamab (TST001) is a humanised monoclonal antibody targeting claudin-18.2, composed of a dimer of the gamma-1 chain and kappa chain of the human-mouse chimeric TST001. It exhibits NK cell-mediated tumour killing activity and is indicated for gastric/gastric-oesophageal junction adenocarcinoma, PDAC, and lung cancer.
Purity:
98.60%
CAS Number:
[2460539-61-9]
Target:
Tight Junction Protein|||Gap Junction Protein
* VAT and and shipping costs not included. Errors and price changes excepted